Christopher Chapman

Christopher C.
Chapman was the founder of Chapman Pharmaceutical Health Foundation, founded in 2006, serving as Chairman from 2006 to 2024.
Dr. Chapman was the founder of Telomir Pharmaceuticals, Inc., founded in 2021, serving as Chairman & Chief Executive Officer from 2022 to 2024.
Dr. Chapman is also the founder of Chapman Pharmaceutical Consulting, Inc...
Former positions include Executive Chairman at MIRA Pharmaceuticals, Inc. from 2023 to 2024; Medical Director at Regeneron Pharmaceuticals, Inc. from 1992 to 1994; President & Director at Rock Creek Pharmaceuticals, Inc. from 2013 to 2015; Director at BioVest International, Inc. in 2004; Independent Director at Accentia Biopharmaceuticals, Inc. from 2012 to 2013; Associate Director-Drug Safety & Pharmacovigilance at Organon Pharmaceuticals USA, Inc. from 2003 to 2004; Executive Director-Medical Affairs at IQVIA RDS Consulting, Inc. from 1995 to 2003; President, Director & Chief Medical Officer at Q from 2021 to 2024; and President & Chief Medical Officer at MyMD Pharmaceuticals (Florida), Inc. from 2020 to 2021.
Education includes a doctorate from Georgetown University School of Medicine conferred in 1987 and an undergraduate degree from Harvard Kennedy School of Government conferred in 2020.